AI coach helps doctors explain prostate cancer tradeoffs
NCT ID NCT06856694
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving doctors and patients a report generated by artificial intelligence can improve how well risks and benefits of prostate cancer treatments are discussed. About 283 men with newly diagnosed prostate cancer and their doctors will be randomly assigned to receive either standard educational materials or the AI-generated feedback report after their consultation. The goal is to see if the feedback helps patients feel less conflicted and make choices that better match their values.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NLP+AI-based feedback report
What this could lead to
If successful, this approach could help doctors communicate risks more clearly and support patients in making more informed treatment choices for prostate cancer.
What could go wrong
This is an early-stage study focused on communication, not a direct treatment. The AI feedback may not change patient outcomes or may not work in all settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States